IRIS
CAMELA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.145
NA - Nord America 1.999
EU - Europa 1.385
SA - Sud America 239
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 72
OC - Oceania 4
AN - Antartide 1
Totale 5.948
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.934
SG - Singapore 909
RU - Federazione Russa 758
CN - Cina 382
VN - Vietnam 373
HK - Hong Kong 223
BR - Brasile 198
DE - Germania 159
IT - Italia 141
FR - Francia 100
IN - India 82
NL - Olanda 50
GB - Regno Unito 43
KR - Corea 37
CA - Canada 31
JP - Giappone 31
UA - Ucraina 28
CI - Costa d'Avorio 24
FI - Finlandia 21
ZA - Sudafrica 18
MX - Messico 15
PL - Polonia 14
BD - Bangladesh 13
SE - Svezia 13
PH - Filippine 12
TR - Turchia 11
AR - Argentina 10
BG - Bulgaria 10
IE - Irlanda 10
IQ - Iraq 10
ES - Italia 9
EC - Ecuador 8
ID - Indonesia 8
TH - Thailandia 8
VE - Venezuela 8
PK - Pakistan 6
UY - Uruguay 6
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
RS - Serbia 5
CR - Costa Rica 4
ET - Etiopia 4
JM - Giamaica 4
LB - Libano 4
PE - Perù 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
EG - Egitto 3
HN - Honduras 3
RO - Romania 3
SN - Senegal 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
BS - Bahamas 2
CG - Congo 2
CH - Svizzera 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SD - Sudan 1
Totale 5.840
Salva come PNG Salva come JPEG
Città #
Singapore 412
San Jose 375
Ashburn 283
Hong Kong 213
Moscow 177
Chandler 150
Hefei 126
Ho Chi Minh City 116
Beijing 113
Santa Clara 98
Hanoi 83
Los Angeles 52
Lauterbourg 50
Amsterdam 37
The Dalles 33
Lawrence 32
Napoli 31
New York 28
Millbury 26
São Paulo 26
Tokyo 26
Seoul 25
Seattle 24
Boston 23
Dallas 22
Munich 22
Naples 22
Buffalo 20
Düsseldorf 20
Redondo Beach 19
Wilmington 19
Houston 18
Kochi 18
Washington 18
Des Moines 17
Menlo Park 15
Frankfurt am Main 14
Da Nang 13
Helsinki 13
Orem 13
Fairfield 12
Haiphong 12
Krefeld 12
Montreal 12
Brooklyn 11
Johannesburg 11
Milan 11
Warsaw 11
Atlanta 10
Council Bluffs 10
Chicago 9
Pune 9
Sofia 9
Woodbridge 9
Can Tho 8
Phoenix 8
Rio de Janeiro 8
San Francisco 8
Chennai 7
Hải Dương 7
Ankara 6
Denver 6
Nuremberg 6
Amman 5
Bhubaneswar 5
Brasília 5
Falkenstein 5
Mexico City 5
Montevideo 5
Portsmouth 5
Querétaro 5
Thái Bình 5
Toronto 5
Belo Horizonte 4
Biên Hòa 4
Bắc Giang 4
Bến Tre 4
Campinas 4
Fremont 4
Guangzhou 4
Kingston 4
Kronberg 4
Lappeenranta 4
London 4
Poplar 4
Redwood City 4
Rome 4
San José 4
Shanghai 4
Stockholm 4
Turku 4
Afragola 3
Baghdad 3
Baku 3
Bucharest 3
Calgary 3
Columbus 3
Dakar 3
Dublin 3
Esslingen am Neckar 3
Totale 3.203
Salva come PNG Salva come JPEG
Nome #
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case 181
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 181
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 179
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 173
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 166
A new dermoscopic pattern for chilblain-COVID-19–like skin lesions in adolescents 146
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 145
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 143
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 136
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 133
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 130
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 130
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 129
Nail changes as manifestation of systemic disease in COVID‐19 infection 129
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 127
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 127
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 127
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 126
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 122
Teledermatology: a useful tool also after Covid-19 era? 121
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 120
Topical oil formulation of plant extracts and vitamins as effective treatment for stretch marks and xerosis—An observational longitudinal study 120
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 118
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 117
Guselkumab is efficacious and safe in psoriasis patients who failed anti-IL17: a 52-week real-life study 116
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 116
Risankizumab treatment in psoriasis patients who failed anti-IL17: a 52-week real-life study 116
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5" 112
Immune response to Covid‐19 mRNA vaccination in psoriasis patients undergoing treatment with biologics 110
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 109
A case of pediatric psoriasis successfully and rapidly treated with ixekizumab 108
Letter to the editor regarding article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610." 108
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al 107
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis? 107
A case of erythrodermic psoriasis successfully treated with apremilast 104
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge 104
A case of erythrodermic psoriasis successfully treated with guselkumab 103
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation 96
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 93
Reply to ‘New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination’ by Merhy et al 91
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: results from an Italian single-centre retrospective study in a real-life setting 86
Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al 80
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 77
New frontiers in personalized medicine in psoriasis 77
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge 75
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 71
Treating psoriasis in the elderly: biologics and small molecules 62
Giant basal cell carcinoma of the vulva successfully treated with Sonidegib 61
A Case of Adult-onset Facial Cutaneous Mastocytoma: Clinical and Dermoscopic Findings 60
Towards Personalized Medicine in Psoriasis: Current Progress 58
Reply to "Routine re-screening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: a single-center retrospective cohort study" 58
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 55
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era? 53
Paradoxical reactions to biologicals for psoriasis 49
Totale 5.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.137
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022277 1 7 0 14 15 6 8 17 63 41 24 81
2022/2023454 37 35 15 17 39 56 49 64 65 36 32 9
2023/2024397 24 46 33 40 38 88 6 51 2 8 48 13
2024/20251.699 74 24 7 14 52 108 153 93 141 259 636 138
2025/20262.878 334 243 281 246 443 134 372 132 373 177 64 79
2026/202772 72 0 0 0 0 0 0 0 0 0 0 0
Totale 5.948